Ursprung des Netzwerks ersten Grades von Elena Spanjaard
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Elena Spanjaard
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sotera Health LLC
Sotera Health LLC Medical/Nursing ServicesHealth Services Sotera Health LLC offers sterilization services. It offers medical device sterilization, pharmaceutical sterilization, food and commercial products safety, packaging materials, laboratory testing, and consulting services. The company was founded in 2017 and is headquartered in Broadview Heights, OH. | Medical/Nursing Services | Director of Finance/CFO | |
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schering-Plough Europe SA | Corporate Officer/Principal | ||
ANAPTYSBIO, INC. | Biotechnology | Director of Finance/CFO | |
University of Pittsburgh | College/University | Corporate Officer/Principal | |
Wayne State University (Michigan) | College/University | Undergraduate Degree | |
Bryan, Garnier & Co Ltd.
Bryan, Garnier & Co Ltd. Investment Banks/BrokersFinance Bryan, Garnier & Co Ltd. is a European, full-service growth-focused independent investment bank for technology, healthcare, consumer, and business services companies. The private company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company is well-positioned in a capex intensive industry that is increasingly dynamic both in capital raising and M & A, driven by the 4th Industrial Revolution. Bryan Garnier is the world's leading independent full-service investment bank for European healthcare and technology-led companies and their investors. The company is focused on new disruptive technologies and alternative production models in a variety of domains geared towards fighting climate change and environmental degradation. The consumer sector is transformed across its segments by the way digital natives relate to brands, products, and the environment. The company was founded in 1996 by Olivier Marie Paul Garnier de Falletans. | Investment Banks/Brokers | Corporate Officer/Principal | |
MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Chairman | |
Hofstra University | College/University | Masters Business Admin | |
Baruch College | College/University | Masters Business Admin | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MEDIVATION INC | Pharmaceuticals: Major | Director of Finance/CFO | |
International Institute for Management Development | College/University | Masters Business Admin | |
Universite Paris Est Creteil Val De Marne | College/University | Doctorate Degree | |
Ecole Supérieure de Commerce de Toulouse | College/University | Graduate Degree | |
Credit Suisse Securities Europe Ltd (Switzerland)
Credit Suisse Securities Europe Ltd (Switzerland) Investment Banks/BrokersFinance Credit Suisse Securities Europe Ltd. (Switzerland) is the Swiss broker/dealer division of Credit Suisse Securities Europe Ltd. in Great Britain. They are ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Headquartered in Zurich, the firm offers equities and fixed income sales and trading services, and provides access to a range of debt and equity securities, derivative products and financing opportunities across the capital spectrum for corporate, sovereign and institutional clients. | Investment Banks/Brokers | Analyst-Equity | |
Macquarie Capital Europe Ltd. (Switzerland)
Macquarie Capital Europe Ltd. (Switzerland) Investment Banks/BrokersFinance Macquarie Capital Europe Ltd. (Switzerland) is the Swiss investment management division of Great Britain-based Macquarie Capital Europe Ltd., ultimately held by Macquarie Group Ltd. (ASX: MQG) in Australia. Headquartered in Geneva, the firm provides risk solutions and market access to global physical and financial commodity for producers, consumers, financial institutions and investors. | Investment Banks/Brokers | Analyst-Equity | |
MedPole SA/NV | Chief Operating Officer Director of Finance/CFO | ||
Université Catholique de Louvain | College/University | Doctorate Degree Undergraduate Degree | |
St. Christopher's Hospital for Children LLC
St. Christopher's Hospital for Children LLC Medical/Nursing ServicesHealth Services St. Christopher's Hospital for Children LLC provides pediatric, children care services, family advisory council, nurturing and culturally diverse environment. Its services include anesthesiology, audiology, cardiology, and center for the urban child, child life program, child protection program, critical care, dental medicine, developmental pediatrics, ear nose throat, emergency, hepatology nutrition and genetics. The company was founded by William H. Bennett on November 30, 1875 and is headquartered in Philadelphia, PA. | Medical/Nursing Services | Corporate Officer/Principal | |
AlchiMedics SA
AlchiMedics SA Chemicals: Major DiversifiedProcess Industries AlchiMedics SA specializes in coating technologies via electrografting. Its products enables covalent adhesion of nano to micrometric polymer-based layers on surfaces. The firm designs, develops and implements electro-grafting technology for implantable biomedical applications. The company was founded in 2007 and is headquartered in Grenoble, France. | Chemicals: Major Diversified | Chairman | |
Miracor Medical SA
Miracor Medical SA Electronic Equipment/InstrumentsElectronic Technology Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria. | Electronic Equipment/Instruments | Director/Board Member | |
Weill Cornell Medical College | College/University | Doctorate Degree | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
IBA Molecular Holding SA
IBA Molecular Holding SA Pharmaceuticals: MajorHealth Technology IBA Molecular Holding SA develops and markets leading edge technologies, pharmaceuticals and tailor made solutions for healthcare with a focus on cancer diagnosis and therapy. The firm serves the medical and healthcare industries. The company is headquartered in Louvain-la-Neuve, Belgium. | Pharmaceuticals: Major | Director of Finance/CFO | |
DIAsource ImmunoAssays SA
DIAsource ImmunoAssays SA BiotechnologyHealth Technology DIAsource ImmunoAssays SA manufactures and distributes clinical diagnostics products. It develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. The firm offer Elisa reader, washer and shaker, along with open and closed fully automated Elisa platforms helping customers to automate their tests. The company was founded in 1996 and is headquartered in Louvain-la-Neuve, Belgium. | Biotechnology | Director of Finance/CFO | |
Astellas Pharmaceuticals SA | Corporate Officer/Principal | ||
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
Medical University of Silesia | College/University | Doctorate Degree | |
ETH Zürich Human Resources | College/University | Doctorate Degree | |
ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
ILKOS THERAPEUTICS, Inc.
ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology ILKOS THERAPEUTICS, Inc. operates as biotechnology firm. It develops drug and clinical solutions for the treatment of venous lower limb ulcers. The company is headquartered in Laval, Canada. | Biotechnology | Director/Board Member | |
REPARE THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
OMEGA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
LYELL IMMUNOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
INSTIL BIO, INC. | Biotechnology | Director/Board Member | |
Karaktero Capital
Karaktero Capital Miscellaneous Commercial ServicesCommercial Services Karaktero Capital specializes in capital markets advisory and investment. The company was founded by Carri Duncan and is headquartered in Leverkusen, Germany. | Miscellaneous Commercial Services | Founder | |
UPMC Children's Hospital of Pittsburgh | Corporate Officer/Principal | ||
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Medical/Nursing Services | Chief Executive Officer | |
VIRACTA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Appia Bio, Inc.
Appia Bio, Inc. BiotechnologyHealth Technology Appia Bio, Inc. is an early stage biotechnology company based in an undisclosed location. Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. The American company utilizes the biology of lymphocyte development with chimeric antigen receptor (CAR) and T cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-NKT) or gamma delta T cells from hematopoietic stem cells (HSCs) with its ACUA (Appia Cells Utilized for Allogeneic) technology platform. The ACUA platform was developed from groundbreaking research in the laboratory of Lili Yang, Ph.D., at the University of California, and collaboration with Appia Bio's other scientific founders, David Baltimore, Ph.D. at Caltech and Pin Wang, Ph.D. at the University of Southern California. The company was founded in 2020 by Jeffrey S. Wiezorek, David Baltimore, Jeenjoo Kang, Lili Yang, Edmund Kim, and Pin Wang. Jeenjoo Kang has been the CEO since 2020. | Biotechnology | Director/Board Member | |
Sermonix Pharmaceuticals LLC
Sermonix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Sermonix Pharmaceuticals LLC operates as a pharmaceutical company that focuses on the development and commercialization of late-stage women?s health products. It offers lasofoxifene, a selective estrogen receptor modulator for the treatment of vulvovaginal atrophy, as well as treatment and prevention of post-menopausal osteoporosis. The company was founded in 2014 by David Portman and is headquartered in Columbus, OH. | Pharmaceuticals: Major | Director/Board Member | |
eureKING SA
eureKING SA Financial ConglomeratesFinance eureKING SA is a special purpose acquisition company, which engages in acquiring one or more companies or operating businesses, through a merger, capital stock exchange, share purchase, asset acquisition, reorganization or similar transaction. It focuses on the completion of an initial business combination with one or several target businesses and companies with principal operations in the biomanufacturing sector. The company was founded by Michael Kloss, Hubert Olivier, Gerard Le Fur, Christophe Jean, Alexandre Mouradian, and Rodolphe Besserve and is headquartered in Paris, France. | Financial Conglomerates | Director/Board Member |
Statistik
International
Vereinigte Staaten | 27 |
Belgien | 8 |
Schweiz | 5 |
Frankreich | 5 |
Vereinigtes Königreich | 4 |
Sektoral
Health Technology | 25 |
Consumer Services | 12 |
Health Services | 5 |
Finance | 5 |
Process Industries | 2 |
Operativ
Corporate Officer/Principal | 23 |
Director/Board Member | 20 |
Director of Finance/CFO | 12 |
Independent Dir/Board Member | 9 |
Doctorate Degree | 6 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Maria Koehler | 11 |
Patrick Jeanmart | 10 |
Margo Roberts | 10 |
Stephen Rubino | 10 |
Christian Homsy | 9 |
Filippo Petti | 9 |
Carri Duncan | 8 |
Dominic Piscitelli | 7 |
David Georges | 4 |
Anne Moore | 4 |
- Börse
- Insiders
- Elena Spanjaard
- Unternehmensverbindungen